Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease

被引：0
作者：
Emmanuil S. Hatzipantelis
Zoe Dorothea Pana
N. Gombakis
A. Taparkou
V. Tzimouli
D. Kleta
D. J. Zafeiriou
V. Garipidou
F. Kanakoudi
M. Athanassiou
机构：
[1] AHEPA University Hospital,2nd Pediatric Department of Aristotle University of Thessaloniki
[2] Hippokration General Hospital,1st Pediatric Department of Aristotle University of Thessaloniki
[3] Hippokration General Hospital,General Haematology Laboratory
[4] Hippokration General Hospital,2nd Propedeutic Department of Internal Medicine
来源：
International Journal of Hematology | 2013年 / 98卷
关键词：
Sickle cell disease; Childhood; ET-1; sP-selectin; Endothelial dysfunction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Sickle cell disease pathogenesis is a complex interplay of multiple factors associated with vascular endothelial activation, intense oxidative stress, and increased sickle cell adhesion. The aim of this study was to determine and compare three panels of plasma circulating biomarkers at ‘steady state’ and during veno-occlusive crises (VOC) in a cohort of children and adolescents with SCD and healthy controls. The following biomarkers were assessed: acute phase reactants, endothelial factors, and adhesion molecules. Forty-one SCD pediatric patients and 28 healthy children were enrolled. Patients at ‘steady state’ presented significantly elevated plasma levels of endothelin-1 (ET-1), soluble-VCAM-1 (sVCAM-1), soluble P-selectin (sP-selectin), and d-dimers compared to the control group. ET-1, sP-selectin, platelet-derived growth factor (PDGF), von Willebrand factor (vWf), d-dimers, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) seems to represent additional, but not independent, prognostic markers of VOC crisis. Elevated plasma levels of sP-selectin, ET-1, and sVCAM-1 were associated with VOC frequency. The present study provides preliminary evidence of a possible association between these biomarkers and the endothelial activation at steady state and VOC in childhood SCD. Further prospective studies are required to confirm the potential independent prognostic value of these markers in different stages of pediatric SCD.
引用
收藏
页码：158 / 163
页数：5
相关论文
共 56 条
  • [1] Stuart MJ(2004)Sickle-cell disease Lancet 364 1343-1360
  • [2] Nagel RL(2009)Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion Hemoglobin 33 1-16
  • [3] Conran N(2009)Sickle red cell–endothelium interactions Microcirculation. 16 97-111
  • [4] Franco-Penteado CF(2009)Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions Am J Hematol 84 618-625
  • [5] Costa FF(2007)Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension and nitric oxide scavenging by cell-free hemoglobin Blood 110 2166-2172
  • [6] Kaul DK(2009)Cardiovascular function and dysfunction in sickle cell anemia J Natl Med Assoc 101 24-30
  • [7] Finnegan E(2010)Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises Br J Haematol 148 797-804
  • [8] Barabino GA(2005)Serum biomarkers for identifying acute chest syndrome among patients who have sickle cell disease and present to the emergency department Pediatrics 116 e420-e425
  • [9] Kato GJ(2005)Endothelial function in patients with sickle cell anemia during and after sickle cell crises J Thromb Thrombolysis 19 83-86
  • [10] Hebbel RP(2008)Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension Haematologica 93 20-26
123456